At a glance
- Originator Bristol-Myers Squibb
- Class Antipsychotics; Benzodiazepines; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Schizophrenia
Most Recent Events
- 29 Jun 2001 No-Development-Reported for Schizophrenia in USA (Unknown route)
- 05 Sep 1997 New profile
- 05 Sep 1997 Preclinical development for Schizophrenia in USA (Unknown route)